[{"orgOrder":0,"company":"Surface Ophthalmics","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Ophthalmology","country":"","productType":"Miscellaneous","year":"2021","type":"Inapplicable","leadProduct":"Mycophenolic Acid","moa":"Inosine-5'-monophosphate dehydrogenase (IMPDH)","graph1":"Ophthalmology","graph2":"Phase II","graph3":"Surface Ophthalmics","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Ophthalmology","amount2New":0,"dosageForm":"Solution","sponsorNew":"Surface Ophthalmics \/ Undisclosed","highestDevelopmentStatusID":"8","companyTruncated":"Surface Ophthalmics \/ Undisclosed"}]

Find Clinical Drug Pipeline Developments & Deals for Mycophenolic Acid

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          PREP
                          Not Confirmed
                          PREP
                          Not Confirmed

                          Details : Mycophenolic Acid is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Dry Eye Syndromes.

                          Product Name : Undisclosed

                          Product Type : Miscellaneous

                          Upfront Cash : Inapplicable

                          February 02, 2021

                          Lead Product(s) : Mycophenolic Acid

                          Therapeutic Area : Ophthalmology

                          Highest Development Status : Phase II

                          Sponsor : Undisclosed

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          02

                          University of Cincinnati

                          Country arrow
                          PREP
                          Not Confirmed

                          University of Cincinnati

                          Country arrow
                          PREP
                          Not Confirmed

                          Details : Mycophenolic Acid is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of undefined medical condition.

                          Product Name : Undisclosed

                          Product Type : Miscellaneous

                          Upfront Cash : Inapplicable

                          April 15, 2011

                          Lead Product(s) : Mycophenolic Acid

                          Therapeutic Area : Undisclosed

                          Highest Development Status : Phase IV

                          Sponsor : Novartis Pharmaceuticals Corporation

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          03

                          Assistance Publique – Hôpitaux de Paris

                          Country arrow
                          PREP
                          Not Confirmed

                          Assistance Publique – Hôpitaux de Paris

                          Country arrow
                          PREP
                          Not Confirmed

                          Details : Myfortic (Mycophenolic Acid) is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Nephrotic Syndrome.

                          Product Name : Myfortic

                          Product Type : Miscellaneous

                          Upfront Cash : Inapplicable

                          September 09, 2010

                          Lead Product(s) : Mycophenolic Acid

                          Therapeutic Area : Nephrology

                          Highest Development Status : Phase III

                          Sponsor : Novartis Pharmaceuticals Corporation

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          04

                          Georgetown University

                          Country arrow
                          PREP
                          Not Confirmed

                          Georgetown University

                          Country arrow
                          PREP
                          Not Confirmed

                          Details : Myfortic (Mycophenolic Acid) is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Kidney Transplantation.

                          Product Name : Myfortic

                          Product Type : Miscellaneous

                          Upfront Cash : Inapplicable

                          June 24, 2010

                          Lead Product(s) : Mycophenolic Acid

                          Therapeutic Area : Immunology

                          Highest Development Status : Phase IV

                          Sponsor : Novartis Pharmaceuticals Corporation

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank